Home Newsfeeds Raymond James Maintains Outperform on CME Group, Lowers Price Target to $235

Raymond James Maintains Outperform on CME Group, Lowers Price Target to $235

Raymond James analyst Patrick O'Shaughnessy maintains CME Group (NASDAQ:CME) with a Outperform and lowers the price target from $254 to $235.

byBenzinga Newsdesk

July 6, 2022

1 minute read

Raymond James analyst Patrick O’Shaughnessy maintains CME Group (NASDAQ:CME) with a Outperform and lowers the price target from $254 to $235.

News

‘Employee Of Chip Equipment Giant ASML Accused Of Stealing Company Secrets Went To Huawei: Report’ – SCMP

By Benzinga Newsdesk

October 25, 9:40 AM

https://www.scmp.com/tech/tech-war/article/3239008/employee-chip-equipment-giant-asml-accused-stealing-company-secrets-went-huawei-report?utm_medium=Social&utm_source=Twitter#Echobox=1698158111-1A former China-based

ASML

Analyst Ratings

Expert Ratings for Kymera Therapeutics

By Benzinga Insights

August 4, 11:03 AM

Within the last quarter, Kymera Therapeutics (NASDAQ:KYMR) has observed the following analyst ratings: Bullish Somewhat Bullish Indifferent Somewhat…

KYMR

Rigetti Computing Awarded DARPA IMPAQT Contract To Advance Quantum Algorithms For Solving Combinatorial Optimization Problems

By Benzinga Newsdesk

October 3, 8:38 AM

Rigetti Computing, Inc. (NASDAQ:RGTI) ("Rigetti" or the "Company"), a pioneer in full-stack quantum-classical computing, today announced that it was awarded a Defense Advanced Research Projects Agency (DARPA) project as

RGTI